Clinically significant anxiety in midlife is associated with increased subsequent dementia risk over an interval of at least 10 years.
Frequency of migraine with or without aura may be correlated with symptoms of anxiety and depression.
Patients previously diagnosed with depression or anxiety did not have a greater risk of Alzheimer's.
Prescriptions for benzodiazepine lasting 2-3 months or more and marked dose increases should be avoided.
A study aimed to clarify the relationship between anxiety and depression in patients with multiple sclerosis.
Interventions with clinical massage or guided imagery may help ease pain and anxiety in patients in a progressive care unit.
Comorbid psychological conditions affect cognitive function in Parkinson's disease, and treatment can be complicated by overlapping symptoms.
Varenicline and bupropion pose a lower risk of serious mental health side effects than was previously thought.
Number of AEDs and seizure frequency also influenced depression in people with epilepsy.
Patients with tension-type headaches had a significantly higher prevalence of anxiety and depression.
There has been a lack of research on the association between anxiety and dementia.
Participants in the yoga/meditation group also showed reduced levels of depression and anxiety.
The psychological consequences of stroke appear to influence outcomes.
Anxiety appeared to affect both verbal and visual memory.
Researchers have uncovered a positive synergistic interaction between Alzheimer's pathology and neuropsychiatric symptoms.
Physical comorbidities are mediated by depression in MS.
The overdose death rate leveled out after 2010.
Associations were mainly significant for 16 mental disorders, including anxiety and substance abuse.
Incorporating mental health screenings in epilepsy appointments may help prevent suicides.
Veterans randomized to mindfulness-based stress reduction reported greater reductions in pain, fatigue, and memory/concentration problems.
Remote counseling may not be suitable for patients with more severe illness.
Researchers saw a reduction in post-op pain, anxiety, and analgesia use in patients under general anesthesia.
The high prevalence of pain in MS patients affects treatment plans.
In chronic pain patients, increased activation of microglia can cause depression and anxiety.
The therapy did seem to improve symptoms of depression and anxiety in some women.
Most of the increase has been among patients who have less serious illness.
When playing with guinea pigs, skin conductance, a measure of anxiety, started to decline.
The effects of binge drinking in adolescence last throughout adulthood, according to results from a study in rats.
While symptoms improved equally in both groups, patients that received a second SGB injection saw even greater improvement.
Air pollutants from fossil fuels and industrial sources can take a toll on both mental and physical health.
Neurology Advisor Articles
- Addressing Rare Headache Disorders: Acute Confusional Migraine
- Organic Solvents Plus Genetics May Increase Risk of Multiple Sclerosis
- No Significant Clinical Differences Between Cluster Headaches With and Without Aura
- Co-Prescription of Opioids and Antidepressants Prevalent in Migraine
- Deep Brain Stimulation May Slow Rest Tremor Progression in Parkinson Disease
- Herpesvirus Abundant in Alzheimer Disease Brain, New Study Finds
- Patients' Preferences for Physician Attire Linked to Perception of Care
- Weighing the Risks of Deep Brain Stimulation
- Grey Matter Atrophy Sequence in Multiple Sclerosis Phenotypes
- Higher Vitamin D Levels Associated With Fewer Lesions in Multiple Sclerosis
- Screening Tool Differentiates Progressive Supranuclear Palsy and Parkinson Disease
- Risk Factors for Impulse Control Behaviors in Parkinson Disease
- Cardiac Pathology in SUDEP Compared With Sudden Arrhythmic or Traumatic Deaths
- 11.2% of U.S. Adults Aged ≥45 Report Subjective Mental Decline
- AMA Aims to Boost Affordability of ACA Marketplace Plans